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Ion channel regulation
Cholesterol binding sites
PIP2 binding sitesWehave shown earlier that Kir2 channels are suppressed by the elevation ofmembrane cholesterol.Moreover, it
is also well known that activation of Kir channels is critically dependent on a regulatory phospholipid,
phosphatidylinositol-4,5-bisphosphate (PIP2). In this study we examined the cross-talk between cholesterol
and PIP2 in the regulation of Kir2 channels. The strength of Kir2–PIP2 interactionswas assessed by acute seques-
tering of PIP2 with neomycin dialyzed into cells through a patch pipette while simultaneously recording whole
cell currents. Consistent with a reduction in PIP2 levels, dialysis of neomycin resulted in a decrease in Kir2.1
and Kir2.3 current amplitudes (current rundown), however, this effect was signiﬁcantly delayed by cholesterol
depletion for both types of channels suggesting that cholesterol depletion strengthens the interaction between
Kir2 channels and PIP2. Furthermore, mutation of Kir2.1 that renders the channels' cholesterol insensitive abro-
gated cholesterol depletion-induced delay in the current rundown whereas reverse mutation in Kir2.3 has the
opposite effect. These observations provide further support for the functional cross-talk between cholesterol
and PIP2 in regulating Kir2 channels. Consistent with these observations, there is a signiﬁcant structural overlap
between cytosolic residues that are critical for the sensitivity of Kir2 channels to the two lipid modulators but
based on recent studies, there is little or no overlap between cholesterol and PIP2 binding sites. Taken together,
these observations suggest that cholesterol and PIP2 regulate the channels through distinct binding sites but that
the signals generated by the binding of the two modulators converge.
© 2014 Rosenhouse-Dantsker et al. Published by Elsevier B.V. on behalf of the Research Network of
Computational and Structural Biotechnology. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Inwardly rectifying K+ channels (Kir) are a major class of potassium
channels that are ubiquitously expressed in numerous cell types and
play central roles in regulating membrane potential and K+ homeosta-
sis [1,2]. A series of studies from our laboratory (eg. [3–5]) and from
other investigators (eg. [6–10]) showed that Kir2 channels are regulat-
ed by two lipid modulators that are integral part of the plasma mem-
brane. These include cholesterol, a major lipid component of the
plasma membrane constituting 10 to 45% of total lipids [11], and phos-
phatidylinositol 4,5-bisphosphate (PIP2), a minor lipid component of
the plasma membrane constituting about 1% of the lipids in the inner
leaﬂet [12], as described in detail in several of our recent reviews
[13–15]. Our studies have shown that most Kir channels are cholesterol
sensitive with the predominant effect being cholesterol-induced sup-
pression of channel function [3–5]. Focusing on Kir2 channels, a major
sub-family of the Kir family, we showed that cholesterol sensitivity ofep, and Allergy, Department of
ood Street (Room 920-N CSB)
414.
ed by Elsevier B.V. on behalf of th
commons.org/licenses/by/4.0/).the channels can be attributed to stabilizing the channels in the closed
state [3,16] and not to the interaction of the channels with caveolin
(Cav-1) [17]. Moreover, we identiﬁed several structural domains that
confer cholesterol sensitivity to the channels: a “cholesterol sensitivity
belt” that confers cholesterol sensitivity to the channels by regulating
the impact of cholesterol on channel gating [18], a “two-waymolecular
switch” that allows switching of cholesterol sensitivity of the channels
by altering interactions between critical residues in the cytosolic do-
main [19] and functional links between the N- and the C-termini [20].
Furthermore, based on studies on cholesterol sensitivity of bacterial ho-
mologues of Kir channels reconstituted into liposomes, we demonstrat-
ed that cholesterol regulates Kir channels through direct sterol–protein
interactions [21,22]. Similarly, a later study showed that puriﬁed Kir2
channels are also sensitive to cholesterol [10]. Finally, we identiﬁed
two novel putative cholesterol binding sites in Kir2.1 channels that are
found in non-annular sites in between the transmembrane helices of
the channels [23].
In contrast to cholesterol, the dominant effect of PIP2 onKir channels
is activation that is attributed to stabilizing the channels in the open
state [7–10]. PIP2 was also found to directly interact with Kir channels
via electrostatic interactions between the negatively charged phosphate
groups of the phosphate head group and positively charged amino acidse Research Network of Computational and Structural Biotechnology. This is an open
132 A. Rosenhouse-Dantsker et al. / Computational and Structural Biotechnology Journal 11 (2014) 131–137in the cytoplasmic domains of the channel (reviewed by [14,24–26]).
Indeed, PIP2 binding sites have been recently identiﬁed by solving the
structure of Kir2.2 channel crystallized with the PIP2 [27].
The effects of the twomodulators on Kir function are clearly distinct:
changes in membrane cholesterol regulate puriﬁed bacterial Kir in the
absence of PIP2 [21,22] and sequestering of cellular PIP2 does not affect
cholesterol sensitivity of Kir2.1 in mammalian cells [16]. Conversely,
PIP2 was shown to activate puriﬁed Kir2 channels in the absence of
cholesterol [28]. However, there is also accumulating evidence that
there is signiﬁcant functional interaction between cholesterol and PIP2
in regulating Kir2 channels. Speciﬁcally, several residues are shown to
play important roles in the sensitivities of the channels to both cho-
lesterol and PIP2 [16,19]. Furthermore, we showed earlier that cho-
lesterol depletion results in a delay in the rundown of the channels'
activity in response to neomycin [16] that is known to sequester
PIP2, an observation that suggests that cholesterol affects Kir–PIP2
interactions. In this study, we provide further evidence that choles-
terol regulates Kir–PIP2 interactions and analyze the structural
overlap between the residues responsible for cholesterol and PIP2
sensitivities of the channels.Control
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Fig. 1. Impact of cholesterol depletion on Kir2.1–PIP2 interactions. A. Representative Kir2.1 curr
pipette. The upper family of traces was recorded in a cell in normal cholesterol conditions and
5 mMMβCD for 1 h. B: The time courses of Kir2.1 rundown in response (1–100 μM) neomycin
lesterol depleted cells. D: The time courses of Kir2.1 rundown in response anti-PIP2 antibodies
condition).2. Materials and methods
2.1. Cells, cholesterol modulation and transfection
Chinese hamster ovary (CHO) K1 cell line was maintained as previ-
ously described [16]. Cholesterol depletion was performed by exposing
the cells to 5mMmethyl-β-cyclodextrin (MβCD) which results in ~50–
60% decrease in the level of membrane cholesterol [4]. MβCD and cho-
lesterol were purchased from Sigma Chemical (St. Louis, MO). Cells
were transiently co-transfected with Kir2.x constructs and eGFP (cmv-
pcDNA3.1-GFP-TOPO, Invitrogen, Carlsbad, CA) using Lipofectamine
(Gibco-BRL, Gaithersburg,MD) according to themanufacturer's instruc-
tions. The experiments were performed 24–48 h after transfection.
2.2. Kir2.x constructs and electrophysiology
Kir2.x constructs were co-transfected with eGFP (cmv-pcDNA3.1-
GFP-TOPO, Invitrogen, Carlsbad, CA) using Lipofectamine (Gibco-BRL)
according to the manufacturer's instructions. Kir2.1-HA and Kir2.3-HA
with the HA tags (inﬂuenza hemagglutinin epitope: YPYDVPDYA)0
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ent traces before (red) and after (green) dialyzing neomycin into the cell through a patch
the lower family of traces recorded from a cell depleted of cholesterol by pre-exposure to
. C: The time courses of Kir2.1 rundown in response 10 μM neomycin in control and cho-
in control and cholesterol depleted cells (all data showmeans + SEM, n = 5–10 cells per
133A. Rosenhouse-Dantsker et al. / Computational and Structural Biotechnology Journal 11 (2014) 131–137inserted into the extracellular domains of the channels were inserted
in a pGW1 vector. Both HA-Kir constructs were a gift of Dr. Carol
Vandenberg. Recordings were performed in whole-cell of the standard
patch clamp technique [29]. Pipettes were pulled (SG10 glass,
1.20 mm ID, 1.60 mm; Part# FPENNU1.20ID1.60OD, Richland Glass,
Richland, NJ) to give a ﬁnal resistance of 2–6MΩ. These pipettes gener-
ated high resistance seals without ﬁre polishing. A saturated salt agar
bridge was used as reference electrode. Currents were recorded using
an EPC9 ampliﬁer (HEKA Electronik, Lambrecht, Germany) and accom-
panying acquisition and analysis software (Pulse & PulseFit, HEKA
Electronik, Lambrecht, Germany). The external recording solution
contained (in mM): 150 NaCl, 6 KCl, 10 HEPES, 1.5 CaCl2, 1 MgCl2, and
1 EGTA, pH 7.3. The pipette solutions contained (in mM): 145 KCl, 10
HEPES, 1 MgCl2, 4 ATP, 1 EGTA, and pH 7.3. Current was monitored by
500ms linear voltage ramps from−160mV to+60mVat an interpulse
interval of 5 s. The holding potential for both protocols was−60 mV.
Pipette and whole cell capacitances were automatically compensat-
ed. Whole cell capacitance and series resistance were compensated
and monitored throughout the recording. Rs was compensated by
60–90% with the compensation being limited by the stability of
the patch. Current density was calculated by normalizing the cur-
rents recorded from individual cells to the capacitance of the same
cell.2.3. Statistical analysis
Statistical signiﬁcance was evaluated using a Standard t-test as-
suming two-tailed distributions with unequal variance. All experi-
ments were performed with 5–10 cells for each experimental
condition.Control
-100 -80 -60 -40 -20 0 20 40
V(mV)
A 
N
or
m
al
iz
ed
 c
ur
re
nt
 d
en
sit
y
B 
C 
N
or
m
al
iz
ed
 c
ur
re
nt
 d
en
sit
y-100 -80 -60 -40 -20 0 20 40
V(mV)
MβCD
60 msec 
20
 p
A 
0
0
0
0
1
1
0
0
0
0
1
1
Fig. 2. Impact of cholesterol depletion on Kir2.3–PIP2 interactions. A. Representative Kir2.1 curr
pipette in a control cell (upper traces) and in a cholesterol depleted cell (lower family). B: The ti
of Kir2.1 rundown in response 1 μM neomycin in control and cholesterol depleted cells (all da3. Results
3.1. Impact of cholesterol depletion on Kir2.1–PIP2 and Kir2.3–PIP2
interactions
3.1.1. Kir2.1
Earlier studies assessed the functional interactions between Kir
channels and PIP2 by over-expressing the channels in Xenopus oocytes
and measuring the rundown of the current in excised inside-out
macropatches with and without perfusing PIP2 to the cytosolic side of
themembrane (eg. [7,8]). These studies showed that Kir currents rapid-
ly decreased after the excision of the patch but could be reactivated by
perfusion of PIP2. Furthermore, the rate of recovery depended on the
strength of the Kir–PIP2 interactions and could be affected by speciﬁc
mutations or by using different PIP2 analogs. Thus, measuring PIP2-
dependent current rundown or recovery was established as a method
to assess the strength of Kir–PIP2 interactions (eg. [7,8]). In our recent
study, we used an alternative approach of dialyzing neomycin, an
agent known to sequester PIP2 by binding to its headgroups and
restricting its ability to interact with proteins [30,31], into the patch pi-
pette in whole-cell conﬁguration [16]. As expected, dialyzing neomycin
into the pipette resulted in Kir2.1 rundown expressed in Chinese ham-
ster ovary cells (CHO) [16]. We also showed that cholesterol depletion
resulted in a signiﬁcant delay in the current rundown of Kir2.1. Since a
faster rundown is interpreted as a weaker Kir–PIP2 interaction [8],
these data led us to hypothesize that cholesterol depletion strengthens
Kir2.1–PIP2 interactions [16]. It is important to note that since the cur-
rents are normalized to the currents recorded at time 0, a delay in
neomycin-induced current rundown cannot be attributed to an increase
in local PIP2 concentration. To further characterize this observation, we
ﬁrst show here that neomycin-induced rundown of Kir2.1 current isTime,sec
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Fig. 3. Impact of reverse mutations Kir2.1 L222I and Kir2.3 I214L on cholesterol depen-
dence of Kir–PIP2 interactions. A: The time courses of Kir2.1 WT and Kir2.1-L222I run-
down in response 10 μM neomycin in control and cholesterol depleted cells. B: The time
courses of Kir2.3 WT and Kir2.3-I214L rundown in response 1 μM neomycin in control
and cholesterol depleted cells (all data showmeans+ SEM, n=5–10 cells per condition).
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Kir2.1 whole cell currents in CHO cells at time 0 before the start of the
dialysis and 60 s after establishing whole-cell conﬁguration that allows
neomycin to diffuse into the cytosol. Fig. 1B shows that the effect is
concentration-dependent with 1 μM of neomycin having no effect
while concentrations of 10 and 100 μM neomycin induce signiﬁcant
rundown. Also, as was shown in our previous study described above,
depletion of the cells of cholesterol using 5mMMβCD results in a signif-
icant delay in the rundown suggesting that cholesterol depletion results
in strengthening of Kir2.1–PIP2 interactions (Fig. 1C). To further verify
that this effect is speciﬁc for PIP2, a complementary series of experi-
ments was performed by dialyzing PIP2 antibodies into the cell. The
rundown in this case is signiﬁcantly slower than with neomycin,
which most likely reﬂects a slower diffusion of the antibodies into the
cell but, more importantly, cholesterol depletion has the same effect of
slowing the rundown process, which points to strengthening Kir2.1–
PIP2 interactions (Fig. 1D). This experiment also excludes the possibili-
ties that the observed delay in the current rundown can be due to the
effect of cholesterol on the neomycin access to the membrane or PIP2-
independent effects of neomycin on channel function. The possibility
that the effect of MβCD on neomycin-induced current rundown can
be independent of cholesterol depletion was excluded in our previous
study by comparing MβCD and MβCD saturated with cholesterol [16].
3.1.2. Kir2.3
Qualitatively similar effects were observed with Kir2.3 channels
(Fig. 2). As expected, since Kir2.3 is known to have a weaker afﬁnity
to PIP2 than Kir2.1, the dose response of the current rundown in re-
sponse to neomycin was shifted to lower concentrations of neomycin
with 1 μMneomycin leading to signiﬁcant rundown (Fig. 2A). More im-
portantly, we show that, similar to Kir2.1, cholesterol depletion resulted
in a signiﬁcant delay in Kir2.3 current rundown when cells were dia-
lyzed with 1 μM neomycin (Fig. 2B). Also, the delay in Kir2.3 rundown
was less pronounced than that in Kir2.1 channels suggesting that the
impact of cholesterol depletion on Kir2.3 channels is weaker than that
on Kir2.1 channels. This observation is indeed consistentwith our previ-
ous studies showing that Kir2.3 is less sensitive to cholesterol than
Kir2.1 [3].
3.2. Reverse mutations Kir2.1 L222I and Kir2.3 I214L Have opposite effects
on cholesterol depletion-induced delays of Kir2.1/Kir2.3 rundown
Our earlier studies showed that a single residue substitution of leu-
cine at position 222 to isoleucine abrogates the sensitivity of Kir2.1
channels to cholesterol whereas the reverse substitution of an isoleu-
cine at a corresponding position of Kir2.3 to leucine increases cholester-
ol sensitivity of Kir2.3 channels [16]. Here, we tested the impact of these
reverse mutations on neomycin-induced current rundown. Our new
data show that L222I substitution abrogates the effect of cholesterol de-
pletion on the kinetics of neomycin-induced Kir2.1 current rundown
(Fig. 3A). As was shown in Fig. 1, the rundown of the WT Kir2.1 is
strongly delayed by cholesterol depletion (see triangle symbols) but
the time courses of L222I Kir2.1 rundown in control and cholesterol de-
pleted cells are identical (circles), indicating that cholesterol depletion
has no effect on the strength of the interaction of Kir2.1 L222I mutants
with PIP2. A loss of the delay effect is consistent with the loss of choles-
terol sensitivity of Kir2.1 L222I described above.
Conversely, I214L substitution enhances the effect of cholesterol de-
pletion on the kinetics of neomycin-induced Kir2.3 rundown (Fig. 3B).
More speciﬁcally, we show here that whereas in the Kir2.3 WT channel
cholesterol depletion resulted in a relatively small delay in the
neomycin-induced current rundown (triangles), the same treatment
resulted in amuch stronger delay in the neomycin-induced current run-
down of the Kir2.3 I214Lmutant (circles). Again, these observations are
consistent with the increased sensitivity of Kir2.3 I214L to cholesterol
compared to the WT Kir2.3 channel that was demonstrated in ourearlier studies [16]. Taken together, data shown in Figs. 3A andB suggest
that cholesterol plays an important role in determining the strength of
Kir–PIP2 interactions.
4. Discussion
Several studies demonstrated that in mammalian cells PIP2 concen-
trates in low-density membrane fractions suggesting that it resides in
cholesterol-rich membrane domains [32,33]. Furthermore, it was also
shown that cholesterol depletion abolishes the localization of PIP2 to
cholesterol-rich membrane fractions [34]. Consistent with these obser-
vations, we showed that cholesterol depletion results in substantial
changes in the localization of ﬂuorescently tagged PIP2 in aortic endo-
thelial cells leading from punctuate to uniform distribution, which in
turn has a signiﬁcant effect on membrane–cytoskeleton adhesion [35].
Cholesterol depletion was also suggested to inhibit PIP2 turnover and
hydrolysis (Kwik et al., 2003). Thus, since both cholesterol and PIP2
are known to regulate Kir channels, it is plausible to expect that the
two effects would be mutually dependent.
One possibility that we explored in our earlier studies is that choles-
terol may regulate Kir channels by regulating their access to PIP2. In-
deed, if cholesterol depletion disperses PIP2 from cholesterol-rich to
cholesterol-poor domains, it might increase the local concentration of
PIP2 near the channels in cholesterol-poor domains and increase Kir ac-
tivity. Our observations, however, show that this is not likely to be the
case because sequestering PIP2 has no effect on cholesterol sensitivity
of Kir2.1 channels [16]. Clearly, an increase in PIP2 hydrolysis also can-
not contribute to the sensitivity of the channels to cholesterol because,
as described above, cholesterol depletion increases Kir2 activity where-
as loss of membrane PIP2 results in the loss in channel function [14]. In
135A. Rosenhouse-Dantsker et al. / Computational and Structural Biotechnology Journal 11 (2014) 131–137this study, we demonstrate an alternative possibility that cholesterol
depletion results in strengthening of Kir2–PIP2 interactions, as assayed
by the rundownof the current in response to PIP2 sequestration. This ef-
fect is consistent with the fact that both cholesterol depletion and the
interaction of the channels with PIP2 result in an increase in Kir2 cur-
rents. The effect of cholesterol depletion-induced strengthening of
Kir2–PIP2 interactions is observed for two major members of the Kir2
subfamily, Kir2.1 and Kir2.3. Furthermore, a single-residue mutation in
Kir2.1 that was shown earlier to abrogate cholesterol sensitivity of the
channel and decrease Kir2.1–PIP2 interactions also abrogates the effect
of cholesterol on Kir2.1–PIP2 interactionswhereas a reversemutation in
Kir2.3 increases cholesterol sensitivity of the channels and strengthens
the effect of cholesterol on Kir2.3–PIP2 interactions.
Is it then possible that cholesterol sensitivity of Kir2 channels might
be fully attributed to regulation of Kir2–PIP2 interactions?Our data does
not support this possibility. First, our recent studies showed that choles-
terol regulates bacterial Kir channels reconstituted in liposomes in the
absence of PIP2 and that this effect critically depends on Kir-
cholesterol binding [21,22]. Even though speciﬁc effects of PIP2 on
Kir2.1 and KirBac1.1 are different, the observations with puriﬁed
KirBac1.1 channels demonstrate that cholesterol can interact with Kir
channels directly. It is not possible, however, to test whether this is
also true for mammalian Kir2 channels because these channels require
PIP2 for activation. We have also shown earlier that in contrast to cho-
lesterol depletion, cholesterol enrichment had no effect on Kir2.1–PIP2
interactions indicating that this mechanism does not contribute to the
suppression of Kir current in cholesterol-enriched cells [16]. We con-
clude, therefore, that strengthening of Kir2–PIP2 interactions may con-
tribute to the sensitivity of mammalian Kir2 channels to cholesterol
depletion but cannot fully account for the sensitivity of the channels
to cholesterol.
Comparing the structural requirements for the sensitivity of the
channels to the two lipid modulators provides further insights into the
crosstalk between the sensitivities of Kir2.1 channels to cholesterolFig. 4. A: Overlap between residues involved in cholesterol or PIP2 sensitivity of Kir2.1. The ﬁgu
tural elements labeled above the sequence. Residues that were found to affect the cholesterol s
residues that were found to play an important role in channel-PIP2 interactions in functional stu
interactions and the sensitivity of the channel to cholesterol. Light brown-ﬁlled red boxes ﬁlled
teractions but does not affect the sensitivity of the channel to cholesterol. Green boxes highlig
B: A lack of overlap between the PIP2-binding site and putative cholesterol-binding sites in Kir2
ture of Kir2.2 (PDB ID 3spi) showing the binding site of PIP2 in the channel (red balls). Also sh
lesterol binding sites in Kir2.1 based on functional data andmolecularmodeling (yellow balls—
residues).and to PIP2 (Fig. 4A). Earlier studies identiﬁed a series of residues in
the cytosolic domains of the channels that affect the strength of the in-
teractions between Kir2.1 and PIP2: speciﬁcally, three “PIP2-sensitive
residues” were identiﬁed in the N-terminus (K50, H53, R67), ﬁve resi-
dues were identiﬁed at the interface between the transmembrane do-
main 2 (TM2) and the C-terminus (K182, K185, K187, K188 and R189)
and eleven were identiﬁed in the C-terminus including the CD loop
(N216, R218, K219 and L222), βD loop (R228), EF loop (N251), and G-
loop (G300, V302, E303, C311 and R312) [19,36,37]. Furthermore, sev-
eral of these residues, or more precisely, the corresponding residues in
Kir2.2 channels, that reside on the interface between the TM and cyto-
solic domains were found to interact directly with PIP2 in crystallogra-
phy studies [27]. We tested a number of the “PIP2 sensitive residues”
for their role in cholesterol sensitivity of the channels and found that
there is a 60% overlap between the two sets: out of 10 “PIP2-sensitive
residues” tested for their sensitivity to cholesterol, 6 residues (H53,
N216, K219, L222, N251, C311)were also found to be important for cho-
lesterol sensitivity of the channels and 4 residues (K182, K185, K187,
R228) were not [16,18,19]. It is also interesting to note that among the
4 residues that are important for the PIP2 sensitivity but not for choles-
terol sensitivity of the channels, themajority are part of the PIP2 binding
site. A signiﬁcant (60%) overlapbetween the residues that are important
for the channel sensitivity to both modulators strongly suggests a com-
mon mechanism.
What is the possible mechanism of the structural overlap between
the residues that confer the sensitivities of the channels to cholesterol
and to PIP2? One obvious possibility would be an overlap of the two
binding sites. This possibility would be consistent with the opposite ef-
fects of cholesterol and PIP2 on channel function because if cholesterol
was to prevent PIP2 from binding to the channel, it would result in
the inhibition of the current and vice versa, cholesterol depletion
would result in increased Kir–PIP2 binding and increase in channel ac-
tivity. However, structural information does not support this possibility:
First, from the analysis described above, we see that the overlapre shows sequence alignment of the Kir2.1 and Kir2.2 channels with key secondary struc-
ensitivity of the channel in functional studies are highlighted yellow. Red boxes highlight
dies. Yellow-ﬁlled red boxes highlight residues whosemutation affects both channel–PIP2
in light brown highlight residues whose mutation to glutamine affects channel–PIP2 in-
ht residues with direct bonding interactions to PIP2 as determined using crystallography.
.2. A ribbon presentation of two adjacent subunits (Gray and light gray) of the crystal struc-
own are the corresponding Kir2.2 residues to Kir2.1 residues that form two putative cho-
direct interaction; light yellowballs— secondary effectwithin 4Å from directly interacting
136 A. Rosenhouse-Dantsker et al. / Computational and Structural Biotechnology Journal 11 (2014) 131–137between the “PIP2 sensitive” and “cholesterol-sensitive” residues actu-
ally excludes residues that interact with PIP2 directly. Indeed, as
shown in Fig. 4B, in agreement with earlier functional data for Kir2.1
[24,36–38], the binding site of PIP2 in Kir2.2 channels is formed of pos-
itively charged residues at the interface between the cytosolic and the
TMdomains [27]. The equivalent site in Kir2.1 is adjacent to the two pu-
tative cholesterol binding sites found in Kir2.1 in our recent studies but
does not overlap with them [23]. The ﬁrst putative cholesterol-binding
site is located between the TM helices of two adjacent channel subunits
whereas the second one is located at the interface between the cytosolic
and transmembrane domains of the channel. The corresponding resi-
dues in Kir2.2 that form these two putative cholesterol binding sites in
Kir2.1 are depicted in Fig. 4B. These data indicate that the two modula-
tors bind to different adjacent non-overlapping sites of the channels and
suggest that functional cross-talk between themmay be due to local in-
teractions between the adjacent binding sites aswell as due to the over-
lap in the intramolecular transduction pathway that leads from
modulator binding to channel gating. Interestingly, a similar possibility
that two modulators may bind to distinct binding sites but then con-
verge in their regulatory function was demonstrated in our recent
study of the cross talk between cholesterol and caveolin in regulating
Kir2.1 channels [17].
In conclusion, we propose the following model: Earlier studies sug-
gested that PIP2 binding to the interface between the TM and the cyto-
solic domains may act as a “glue” between the cytosolic tails of the
channels exerting a mechanical force for the channels to open [24].
We propose here that binding of cholesterol in between the helices of
the TM domain exerts the opposite effect making it more difﬁcult for
the TM helices to move into the open conformation of the channels,
thus stabilizing the channels in the closed state. This working hypothe-
sis is demonstrated in Fig. 5when cholesterol binds between the TMhe-
lices of the channels, it interferes with the tilt of the TM2 domain
necessary for the channel opening and weakens the strength of the in-
teraction between the channel and PIP2 (Fig. 5: left). It is also important
to note, however, that cholesterol does not necessarily prevent PIP2
from binding to the channel. In contrast, removal of cholesterol from
its binding sites in the Kir2 channel allows the TM2 domain to tilt into
an open conformation and enhances PIP2 binding at the interface be-
tween the cytosolic and TM domains of the channels that stabilizes
the channels in the open state (Fig. 5: right). Clearly, however, more
studies are needed to test this hypothesis.
It is also important to note that the opposite effects of cholesterol
and PIP2 have been reported for multiple types of ion channels. Indeed,
similar to Kir2.1 channels, thedominant effect of cholesterol onmultipleC-Terminus 
PI
P2
 
PI
P2
 
N-Terminus N-Terminus 
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Fig. 5. Schematic model of cholesterol andtypes of ion channels, including other types of Kir and several types of
voltage-gated K+, Na+ and Ca+2 channels is to suppress channel activ-
ity [14], whereas the most common effect of PIP2 is to increase channel
activity of the same channels [39]. Little is known however about the
functional cross-talk between the two lipid modulators in regulating
other types of ion channels. Our current study proposes a new model
for the interplay between these twomodulators in regulating ion chan-
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